Medical device companies need 3D-animations to explain how their products work in the body. In these narratives, we focus on highlighting technological advancements and marketplace advantages of our clients products.
This 3D animation depicts HIV Protease, an enzyme responsible for cleaving amino acids chains created by ribosomes, before packaging into new viruses. Of interest to the biotech and scientific community is the rate of mutation this protein undergoes as a result of drug interactions. Identifying these residues and in turn modifying drugs to prevent this mutation allows new drugs to offer a new hope for better treatment outcomes.